Despite its overall effectiveness, the response to Fildena 50 Mg may vary among individuals due to genetic differences. Genetic factors can influence drug metabolism, receptor sensitivity, and pharmacodynamics effects, leading to differences in treatment outcomes. Pharmacokinetic studies aim to identify genetic markers that could predict individual responses to Fildena 50 Mg, allowing for personalized treatment approaches. The integration of genetics into ED management holds promise for personalized medicine approaches tailored to individual patients' needs. As our understanding of the genetic basis of ED continues to evolve, so too will the development of novel treatment strategies and therapeutic targets. https://www.flatmeds.com/product/fildena-50-mg/